Liquid AI's LFM2 Beats GPT-5 and Claude on Aging Research Tasks
This story is from 2026-09-17. It is preserved in the archive; the latest stories are on the live feed.
Liquid AI and Insilico Medicine released two small LFM2 variants that beat GPT-5, Gemini-3.1-Pro, and Claude Opus on aging biology benchmarks.
Read the full story at AlphaSignal ↗
Timeline · 1 report
- 2026-09-17 15:29 · AlphaSignal
Liquid AI's LFM2 Beats GPT-5 and Claude on Aging Research Tasks